Elevance Lifts Adjusted EPS Floor to at Least $29, Reaffirms at Least 12% 2027 Growth

Elevance Health raised its 2026 adjusted diluted earnings per share floor to at least $29 and reaffirmed confidence in at least 12% growth in 2027, measured against a separate earnings baseline of at least $26.75 per share.

The company lifted its 2026 adjusted diluted EPS floor from at least $27 on Wednesday. It also raised its separate GAAP diluted EPS floor to at least $22 from $20.10.

The 2027 growth rate is based on a 2026 adjusted earnings baseline that excludes nonrecurring net investment income, other nonoperating items and targeted one-time investments. Elevance did not provide a specific 2027 per-share forecast.

Adjusted diluted EPS is a non-GAAP measure intended to help compare results across periods; it is not a replacement for GAAP measures. Details of the revised 2026 forecast and third-quarter results were covered earlier.